Nika Pharmaceuticals, Inc
NIKA· OTC
NIKANika Pharmaceuticals, Inc
Filed Aug 22, 2022 · 10-Q · 53 days after period end · 0001826466-22-000111
| Metric | Q2 2022 | Q2 2021 |
|---|---|---|
| Revenue | $0.00 | — |
| Net Income | $3.16M | -$2.96K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nika Pharmaceuticals, Inc · CIK 1145604 · Engraved from SEC EDGAR
ended Jun 30, 2022 · filed Aug 22, 2022 · 53 d after period end
